Great point about the effective osmole removal! I did not consider that. Thanks for bringing it up. This would certainly be relevant for IHD, especially if baseline serum tonicity is significantly higher than that of the dialysate. Although I would imagine that this effect would be very blunt with CRRT and as such should not cause "acute" hemodynamic instability although slow loss of ECF volume may be seen. Plus, as you indicated, this effect is dependent on the baseline serum tonicity. On the contrary, if the baseline tonicity is lower than that of the dialysate (e.g. hyponatremia), RRT may instead lead to a gain of effective osmoles and therefore expansion of the ECF compartment. (Correct me if I'm wrong.)
Unrelated question - do you usually use a different Na bath in a standard patient? I have seen 140 for most cases. Also, I couldn't grasp how they can become hyperatremic with a Na bath of 140. My understanding is that the process of diffusion basically strives to equilibrate concentrations on either side, so a dialysate Na of 140 over time should drive the blood Na to 140? Thanks!
For a standard patient, I usually use a Na bath of 137 mmol/L. Maybe I'm making mountains out of mole hills but I believe that there's a lot of fine-tuning that one can do to the dialysate bath that ultimately has a significant clinical effect on the patient. The following excerpt from a journal article illustrates some of the intricacies that I am referring to with regards to choosing a Na bath:
RELATIONSHIP OF DIALYSATE SODIUM WITH [INTERDIALYTIC WEIGHT GAIN (IDWG)] AND HYPERTENSION
Although our current approach to reduce volume overload with dietary salt restriction may decrease left ventricular hypertrophy,52 hypertension,53,54 and IDWG,53 the benefits may be muted due to the difficulty of long-lasting lifestyle and behavioral modification resulting in poor compliance. In recent years, attention has shifted to the “other salt,” dialysate sodium, a prerequisite for the delivery of HD.
The link between high dialysate sodium concentration with increased IDWG and worsening hypertension has been reported since the very early interventional studies comparing high dialysate sodium (≥145 mEq/L) with low dialysate sodium (132-133 mEq/L) to reduce intradialytic symptoms including hypotension.55,56 Subsequent studies showed that while changes in dialysate sodium concentration from 130 to 136 mEq/L reduced the incidence of cramps, sodium diffusion increased with subsequent thirst, IDWG, and increased mean arterial pressure.27,57 Several studies have consistently shown that higher sodium dialysate concentration resulted in increased postdialysis plasma sodium level.31,58-60 While data for actual sodium loading are scant, the principles of the elegant early study by Van Stone et al60 examining higher dialysate sodium effects to overcome HD-associated side effects remain valid concepts. When dialysate sodium concentration exceeds serum sodium level, water shifts from the intracellular to the extracellular space, resulting in fluid removal from both compartments. In the presence of lower dialysate sodium concentration, the opposite occurs, with water moving into the intracellular space. Thus, identical ultrafiltration volumes with high dialysate sodium concentration results in lower plasma volume removal compared to lower dialysate sodium concentration.
Mendoza JM, Arramreddy R, Schiller B. Dialysate Sodium: Choosing the Optimal Hemodialysis Bath. Am J Kidney Dis. 66(4):710-720.
You're correct that using a Na bath of 140 mmol/L would not make one hypernatremic. I should have used a more accurate description of what I meant. Essentially, if serum Na goes above 140 mmol/L, it then triggers the thirst mechanism which is still intact in those with ESRD. This makes the patient more prone to drinking excessive amounts of fluid which would then cause volume overload and all of its bad consequences (higher BPs, edema, worsening of left ventricular hypertrophy, etc.). It's true that the patient will eventually drink but I would like to think that I at least made some mitigation in avoiding excessive interdialytic weight gain.